Financials

News Ideas Minds Technicals

301089 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to TUOXIN PHARM GP CO operating, investing, and financing activities

301089 free cash flow for Q1 24 is 38.17 M CNY. For 2023, 301089 free cash flow was -151.7 M CNY and operating cash flow was 33.52 M CNY.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CNY

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—